Bromelain topical - MediWound

Drug Profile

Bromelain topical - MediWound

Alternative Names: Debrase; Debrase Gel Dressing; NexoBrid; NexoBridN

Latest Information Update: 20 May 2017

Price : $50

At a glance

  • Originator MediWound
  • Developer MediWound; Teva Pharmaceutical Industries; Tuteur
  • Class Anti-inflammatories; Cysteine endopeptidases; Skin disorder therapies
  • Mechanism of Action Peptide hydrolase replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Burns
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Burns

Most Recent Events

  • 30 Jun 2016 Launched for Burns in Argentina (Topical)
  • 26 Apr 2016 Bromelain topical licensed to Kaken Pharmaceuticals in Japan
  • 03 Mar 2016 Bromelain topical licensed to Learning Organized in India, Bangladesh and Sri Lanka
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top